Freestone Capital Holdings, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1470876 Seattle, WA

Position in VRTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$401,886

+$16,984 QoQ

Shares Held

900

+6.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Freestone Capital Holdings, LLC holds $6,301,304 across 14 Biotechnology names. VRTX ranks #4 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABUS	Arbutus Biopharma Corp	442,500	$1,991,250
2	IMNM	Immunome Inc.	61,514	$1,345,311
3	BNTX	BioNTech SE	7,914	$703,396
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	900	$401,886
5	REGN	Regeneron Pharmaceuticals, Inc.	464	$358,504
6	RYTM	Rhythm Pharmaceuticals, Inc.	3,700	$321,789
7	EXEL	Exelixis, Inc.	7,001	$300,272
8	RVMD	Revolution Medicines, Inc.	2,109	$205,100

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$401,886	900	+6.0%	Shares	Defined	2026-05-13
2025-12-31	$384,902	849	-6.9%	Shares	Defined	2026-01-23
2025-09-30	$357,175	912	-10.2%	Shares	Defined	2025-11-12
2022-06-30	$286,298	1,016	-28.1%	Shares	Defined	2022-08-09
2022-03-31	$368,750	1,413	-3.0%	Shares	Defined	2022-05-12
2021-12-31	$319,737	1,456	+17.0%	Shares	Defined	2022-02-14
2021-06-30	$250,827	1,244	-3.0%	Shares	Defined	2021-08-16
2021-03-31	$275,488	1,282	+34.1%	Shares	Defined	2021-05-17
2020-12-31	$225,941	956	+32.4%	Shares	Defined	2021-02-16
2020-09-30	$196,470	722	—	Shares	Defined	2020-11-06
No filing history on record for this holder in this stock.